Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Could this be what is happening to PTSC?

 I'm almost certain both parties agreed to a 'stay' submitted to JW.  You're quoting an article from last March. Certainly PTSC/TPL & J2.5 were aware of this.

Did NTP have a Markman as favorable ?  Also the 'stay' has no timetable. TPL/PTSC & J2.5 are a distinct 30 days. The USPTO would have no part of being cornered into making a hurried ruling.

 The 'stay' that we've encountered can only be interpreted as a medium for settlement. IMO

 I also think the market agrees with me since PTSCs' PPS has risen a full 50 % since the 'stay' order.

 

    Long & Strong 

 

Share
New Message
Please login to post a reply